BBPvsTHNRETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) and Amplify Weight Loss Drug & Treatment ETF (THNR) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.59% for THNR. BBP is up 21.54% year-to-date (YTD) with +$40M in YTD flows. THNR performs worse with 1.97% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of BBP and THNR below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs THNR performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP THNR | +0.94%-0.57% | +15.67%+7.01% | +21.54%+1.97% | +56.59%+10.18% | +81.31%n/a | +94.15%n/a |
| Flows | BBP THNR | +$10M+$769K | +$28M+$769K | +$40M+$2M | +$52M+$2M | +$55M- | +$48M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP THNR | +26.32%+19.14% | +24.02%+17.87% | +24.33%n/a | +26.47%n/a |
| Max drawdown | BBP THNR | -7.49%-5.17% | -9.59%-12.38% | -25.54%n/a | -37.61%n/a |
| Max drawdown duration | BBP THNR | 44d20d | 48d160d | 292dn/a | 586dn/a |
Trading data
BBP | THNR | |
Last sale 7/28/2026 at 1:30 PM | $97.69 | $26.09 |
| Previous close 07/27/2026 | $97.26 | $25.75 |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | THNR | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
BBP | THNR | |
|---|---|---|
| Last price | $97.69 | $26.09 |
| 1D performance | +0.45% | +1.29% |
| AuM | $96.94 M | $5.14 M |
| E/R | 0.34% | 0.59% |
Characteristics
BBP | THNR | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Amplify ETFs |
| Benchmark | LifeSci Biotechnology Products Index | VettaFi Weight Loss Drug & Treatment Index |
| N° of holdings | 66 | 20 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | May 21, 2024 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
89.11%
Other
10.89%
THNR
USA
58.22%
Denmark
13.37%
China
11.24%
Other
17.17%
Sectors
BBP
Healthcare
89.47%
Other
10.53%
THNR
Healthcare
99.22%
Other
0.78%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
87.15%
THNR
Total weight of top 15 holdings out of 15
85.06%
Top 15 holdings
Data as of June 30, 2026
BBP
Verastem, Inc.
44.58%
Legend Biotech Corp.
41.98%
Agios Pharmaceuticals, Inc.
0.05%
BioCryst Pharmaceuticals, Inc.
0.05%
BioMarin Pharmaceutical, Inc.
0.05%
Rigel Pharmaceuticals, Inc.
0.05%
Crinetics Pharmaceuticals, Inc.
0.05%
Madrigal Pharmaceuticals, Inc.
0.05%
BioNTech SE
0.05%
Iovance Biotherapeutics, Inc.
0.05%
Rhythm Pharmaceuticals, Inc.
0.05%
Alnylam Pharmaceuticals, Inc.
0.05%
Incyte Corp.
0.05%
Sarepta Therapeutics, Inc.
0.05%
Omeros Corp.
0.05%
THNR
Novo Nordisk A/S
9.91%
Eli Lilly & Co.
9.45%
Scholar Rock Holding Corp.
5.76%
Hims & Hers Health, Inc.
5.53%
Viking Therapeutics, Inc.
5.43%
AbbVie, Inc.
5.30%
Regeneron Pharmaceuticals, Inc.
5.01%
Merck & Co., Inc.
5.01%
AstraZeneca PLC
5.00%
Arrowhead Pharmaceuticals, Inc.
4.99%
Roche Holding AG
4.95%
Amgen, Inc.
4.90%
Innovent Biologics, Inc.
4.78%
Chugai Pharmaceutical Co., Ltd.
4.55%
Pfizer Inc.
4.49%
Frequently asked questions about BBP and THNR
How have the BBP and THNR ETFs performed in 2026?
As of July 27, 2026, BBP is up 21.54% year-to-date (YTD), while THNR has returned 1.97%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or THNR?
Year-to-date, the BBP ETF saw +$40M in flows, compared to +$2M for THNR.
Which ETF is more volatile: BBP or THNR?
Over the past year, BBP had a volatility of 24.02%, while THNR experienced 17.87%.
Which ETF is bigger: BBP or THNR?
As of July 27, 2026, BBP holds $96.94 M in assets under management (AUM), while THNR manages $5.14 M.
What sectors do the BBP and THNR ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, THNR focuses on Healthcare.
What are the top holdings of the BBP ETF and THNR ETF?
BBP top holdings include Verastem, Inc., Legend Biotech Corp. and Agios Pharmaceuticals, Inc.. THNR holds in its top three: Novo Nordisk A/S, Eli Lilly & Co. and Scholar Rock Holding Corp..
Which ETF is more diversified: BBP or THNR?
BBP holds 66 securities with 87.15% of its assets in the top 15. THNR has 20 securities and a top 15 weight of 85.06%.
Advertisement
Latest news about BBP & THNR
Advertisement
Advertisement
